Caroline is a business leader, physician, and lawyer with more than 30 years of experience across medical technology, diagnostics, life sciences, commercialization strategy, and healthcare innovation. With training as an internist and pathologist, she brings a rare combination of clinical insight, business leadership, legal perspective, and market strategy to her work with emerging companies and technology-enabled healthcare organizations. Caroline has advised and built healthcare, diagnostics, and life science tools companies from early financing through exit, supporting team formation, facility development, intellectual property strategy, financing, partnership development, regulatory planning, and commercialization. She works with founders and leadership teams to evaluate technologies in the context of clinical need, market dynamics, policy shifts, competitive trends, and global commercialization opportunities. Her experience includes operational and strategic roles at BD, where she helped create the BD QIAGEN joint venture and molecular diagnostics business unit, as well as leadership roles at bioMérieux and MDS Proteomics. She later founded Popper and Company, a strategy consulting firm, and co-founded The Sherpanis with Julie Wilkinson. Caroline has also served as Chief Commercial Officer of Johns Hopkins Precision Medicine, where she worked closely with clinicians, data scientists, and collaborators on issues related to privacy, cloud storage, data federation, and commercialization. She also led commercialization activities for the Johns Hopkins Applied Physics Lab Healthcare Mission Area. Her expertise spans technology assessment, commercialization strategy, global market development, data strategy, privacy, compliance, corporate governance, regulatory considerations, and the translation of academic innovation into market-ready products and services. She currently serves as co-chair of the American Bar Association Healthcare Section AI Task Force, reflecting her continued focus on the intersection of healthcare, biology, technology, and artificial intelligence.